Markus Elsner

Wenigstens scheint die ganz restriktive Version vom Tisch zu sein

»Veggieburger«: Namensverbot in der EU vorerst gescheitert Das EU-Parlament votierte im Herbst für ein Namensverbot für Fleischalternativen. Nun gibt es einen Kompromiss, der lediglich tierische Bezeichnungen betreffen soll. Die Veggiebranche sieht dennoch ei...

So ein Quatsch:
www.spiegel.de/wirtschaft/s...

GDPR is killing me. It really does.

Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential - npj Biomedical Innovations npj Biomedical Innovations - Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential

I’m pleased to share our lab’s first paper (a review), highlighting new insights into macrophages, their mechanobiology, and cancer therapeutic potential through both genetic and non-genetic approaches. @jacobsschool.bsky.social.

www.nature.com/articles/s44...

Impressive list of titles to choose from 😂

Why We Must Act Now in Biomedical Engineering Germany has the opportunity to extend its strength as an engineering powerhouse into medicine and the life sciences. Vasilis Ntziachristos

Germany has the opportunity to extend its strength as an engineering powerhouse into medicine and the life sciences. Vasilis Ntziachristos explains how this can be achieved using three key levers.

A comment by Vasilis Ntziachristos @helmholtzmunich.bsky.social

www.helmholtz.de/en/newsroom/...

From mutant mice to meaningful signals: Read about Nobel laureate Fred Ramsdell’s #AACRIO26 keynote on regulatory T cells and immune tolerance on the #AACRBlog: buff.ly/N6PBOS4 #AACRBlog

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection www.nature.com/articles/s4...

Watching White Lotus (late to the game ...).
Really painful to watch sometimes...

😮

Apply for 'Translating Discoveries to the Bedside: A Medical Devices Course,' a professional development program from @childrensphila.bsky.social & @upenn.edu for clinicians and scientists interested in translating research into real-world healthcare solutions www.research.chop.edu/service/medi...

Overcoming functional and translational challenges of cellular immunotherapies for solid tumors Though successful in hematologic cancers, cell therapies face major barriers in solid tumors. Chen et al. review functional and translational obstacles undermining autologous and allogeneic cell-based therapies for solid tumors. They assess key impediments, contributing factors, and emerging solutions, emphasizing engineering advances and new technologies to enable next-generation cellular immunotherapies.

Online Now: Overcoming functional and translational challenges of cellular immunotherapies for solid tumors

Intratumoral lymphatics: When less is more Lymphatic vessels assume two-faced roles in cancer, functioning as facilitators of both immune surveillance and metastasis. In this issue of Cancer Cell, Karakousi et al. establish IFNγ as a key phenotypic and metabolic switch in tumor-associated lymphatic vessels that reinforces antitumor immunity while simultaneously blocking regional metastasis.

Online Now: Intratumoral lymphatics: When less is more

A disease model resource reveals core principles of tissue-specific cancer evolution - Nature The Mouse Cancer Cell line Atlas (MCCA) provides major advances towards a mechanistic understanding of cancer genomes.

new out in Nature www.nature.com/articles/s41...

Macrophages: Targets for next-generation cancer immunotherapy Tumor-associated macrophages sit at the crossroads of immune suppression and tumor destruction, prompting renewed interest in how their biology can be therapeutically redirected. Sun et al. synthesize recent advances in macrophage heterogeneity, engineering, and targeted reprogramming to highlight next-generation strategies that could turn macrophages into a powerful and versatile arm of cancer immunotherapy.

Online Now: Macrophages: Targets for next-generation cancer immunotherapy

It is time to plan your next course of #LSFM #LISH #Lightsheet
It will take place for the second time in @mdibl.org, next to Bar Harbour and you can enjoy the Acadia National Park but also join me to swim everyday in a refreshing ocean!
Join us!
mdibl.org/course/lsfm-...

Are you a computational postdoc or even in the last year of your PhD and you want to set up your own lab? Want to work in one of the most multi-disciplinary and multi-national institutions in the world? Want to be a leader in understanding biology - molecules up? Apply below!

EU pushes for broad changes to biotech rules as China gains ground - Nature Biotechnology The European Commission is proposing sweeping new legislation aimed at reinvigorating Europe’s biotech sector.

The European Commission is proposing sweeping new legislation aimed at reinvigorating Europe’s biotech sector www.nature.com/articles/s41...
[🔓read free with login]

Language model-guided anticipation and discovery of mammalian metabolites - Nature Chemical language models trained on known metabolites can identify previously unknown metabolites from mass spectrometry-based metabolomics data with high accuracy.

'We develop approaches to integrate DeepMet with mass spectrometry-based metabolomics data that enable de novo identification of metabolites in complex tissues and harness these approaches to reveal several dozen previously unrecognized metabolites.'
www.nature.com/articles/s41...

Do you: Have a strong interest in science? A passion for journalism and writing? Our paid 3-month internship might be for you! We are looking for talented candidates from all backgrounds, especially those traditionally underrepresented in publishing. Applications close 9 March 2026.

Calling all budding science writers!

Applications for our paid London-based internship, starting in June, are now open.

Deadline: 9 March 2026

Full info here: springernature.wd3.myworkdayjobs.com/en-US/Spring...

#PaidInternship #Internship #Journalism

Theo Müller scheitert mit Eilantrag Die Organisation Campact darf behaupten, der Molkereiunternehmer unterstütze die AfD.

Weshalb ich keine Müller Produkte kaufe (Müller Milch, Weihenstephan, Landliebe, Hochwald Milch):
www.sueddeutsche.de/wirtschaft/m...

copyright Palina Nepachalovich of ZML Dresden

Ups we did it again! Please mark your calender. EMBO Workshop “Lipid Code to Life”, taking place September 7–11, 2026, in Dresden, organized by Maria Fedorova, @lipid.bsky.social, Valerie O'Donnell, @holthuislab.bsky.social and @molcellbiophys-lab.bsky.social 🥳 Retweets = lipidlove

Ü40 Witze :)

Comic in zwei Bildern: Oben eine Küche mit Arbeitsflächen links und rechts, hinten ein Fenster mit grünem Ausblick. Links sitzt ein Mann auf einem Hocker an der Arbeitsplatte, rechts steht eine Frau, beide schauen auf ein kleines Mädchen mit lockigen blonden Haaren, das mittig im Vordergrund steht. Aus einer Sprechblase über dem Mann kommt die Frage: „…was möchtest du denn in deine Brotdose?“ Das Mädchen antwortet in einer Sprechblase: „Ein belegtes Brot mit Schinken“. Im unteren Bild ist dieselbe Küchenszene zu sehen, nur dass das Kind jetzt nicht mehr sichtbar ist und der Mann und die Frau die Arme nach oben reißen, als würden sie jubelnd "singen" oder "rufen". Über ihnen dominiert eine riesige, gezackte Sprechblase mit dem Wort „SCHINKEN!!“ in großen, handgezeichneten Blockbuchstaben.

🤭 Versteht bestimmt auch nicht mehr jeder 🎸.

Why is my brain always lying to me?

How far back in time can you understand English? An experiment in language change

www.deadlanguagesociety.com/p/how-far-ba...

I cannot speak as to the accuracy of the piece yet I found it a fascinating exercise @adamroberts.bsky.social @drlauravarnam.bsky.social

Wer unsere Arbeit unterstützen möchte, darf das natürlich sehr gerne:
sicherheitspod.de/spenden/

Neoantigen-targeted CAR T cell therapy against solid tumors shows great potential for future clinical trials in patients with KRASG12V/HLA-A*02:01
www.science.org/doi/10.1126/...

Nature Medicine to investigate study that found cancer treatment is better in morning Nature Medicine starts an investigation into inconsistencies in a study that found it was better to have immunotherapy in the morning.

www.statnews.com/2026/02/20/c...
i hope they can get the data from the authors. I was told by the editor that data weren’t available because of patient confidentiality- so many authors use that excuse , it makes data sharing policies worthless